CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Defibrillation using the Extravascular ICDdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03608670
NCT03608670N/ACompleted
CompareCT.gov

Extravascular ICD Pilot Study

Medtronic Cardiac Rhythm and Heart Failure·interventional·Posted Aug 1, 2018·Updated Jan 8, 2024

In Brief

A clinical study evaluating Defibrillation using the Extravascular ICD for Tachycardia and Ventricular Arrythmia. Completed, enrolled 26 participants across 4 sites in 2 countries.

Detailed Summary

The proposed study is designed to characterize the safety and efficacy of a new extravascular implantable cardioverter defibrillator (ICD) system in humans.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTachycardia, Ventricular Arrythmia
CountriesAustralia, New Zealand
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 1, 2018
Enrollment StartJul 17, 2018
Primary CompletionMar 11, 2019
Study CompletionNov 15, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.9 years ago

Interventions

Defibrillation using the Extravascular ICDdevice

VT/VF induction attempted for defibrillation testing, as well as requisite electrical testing.